Literature DB >> 7619489

Variable region sequence modulates periplasmic export of a single-chain Fv antibody fragment in Escherichia coli.

M Ayala1, R F Balint, L Fernández-de-Cossío, J W Canaán-Haden, J W Larrick, J V Gavilondo.   

Abstract

Using PCR, we have cloned antibody heavy and light chain variable region (VH and VL) coding sequences specific for a recombinant hepatitis B virus surface antigen (HBsAg) and assembled these for expression as single-chain Fv (scFv) fragments in Escherichia coli periplasm using the ompA signal peptide. The vectors also encoded N- or C-terminal His6 extensions to allow for the purification of the expressed proteins using immobilized metal affinity chromatography (IMAC). We found that the VH-linker-VL configuration of the scFv was not exported to the periplasm but remained associated with cellular insoluble material, from which it could be extracted, renatured to its active form by gentle dialysis and purified using IMAC. The molecular size of the scFv suggests that the ompA signal peptide was not processed. Based on previous reports, we hypothesized that the arginine in framework 1 (FR1) of the VH might interfere with translocation to the periplasm by means of the signal peptide. Because no arginines are present in FR1 of VL, we reversed the order of the V-regions in the scFv and observed efficient export of the active scFv to the periplasm. Furthermore, when the arginine in FR1 of VH was mutated to glycine in the original VH-linker-VL construct, active scFv was also exported to the periplasm. Thus, exposed positive charges near the signal peptide may account for at least some of the often-encountered difficulties in bacterial scFv expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7619489

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  5 in total

1.  Expression of a single-chain Fv antibody fragment specific for the hepatitis B surface antigen in transgenic tobacco plants.

Authors:  Nadia Ramírez; Marta Ayala; Damaryst Lorenzo; Daniel Palenzuela; Lissett Herrera; Vivian Doreste; Marlene Pérez; Jorge V Gavilond; Pedro Oramas
Journal:  Transgenic Res       Date:  2002-02       Impact factor: 2.788

2.  The mosaic puzzle of the therapeutic monoclonal antibodies and antibody fragments - A modular transition from full-length immunoglobulins to antibody mimetics.

Authors:  Sami El Khatib; Mohamed Salla
Journal:  Leuk Res Rep       Date:  2022-06-27

3.  Expression of recombinant antibody (single chain antibody fragment) in transgenic plant Nicotiana tabacum cv. Xanthi.

Authors:  S Dobhal; V K Chaudhary; A Singh; D Pandey; A Kumar; S Agrawal
Journal:  Mol Biol Rep       Date:  2013-11-12       Impact factor: 2.316

4.  Functional production and characterization of a fibrin-specific single-chain antibody fragment from Bacillus subtilis: effects of molecular chaperones and a wall-bound protease on antibody fragment production.

Authors:  Sau-Ching Wu; Jonathan C Yeung; Yanjun Duan; Ruiqiong Ye; Steven J Szarka; Hamid R Habibi; Sui-Lam Wong
Journal:  Appl Environ Microbiol       Date:  2002-07       Impact factor: 4.792

5.  Effective therapeutic approach for head and neck cancer by an engineered minibody targeting the EGFR receptor.

Authors:  Young Pil Kim; Dongsun Park; Jae Jin Kim; Won-Jae Chi; Won-Jae Choi; Sun Hee Lee; Seo Yun Lee; Soyeon Kim; Jee Min Chung; Jinseon Jeon; Byoung Dae Lee; Joo-Ho Shin; Yun-Il Lee; Hyeseong Cho; Jeong-Min Lee; Ho Chul Kang
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.